In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given ...

When it comes to employees’ health and safety, manufacturing remains one of Australia’s most high-risk industries, both for employees and company Directors.